Table 2. In vitro naïve T cell proliferation correlates with magnitude of response to immunization with neoantigen, but not prevalent antigen.
In vitro T cell proliferation | Response to KLH immunization |
Response to TT immunization |
||||
---|---|---|---|---|---|---|
LPAa | DTHb | ABtc | LPAa | DTHb | ABtc | |
Vβ3+ CD4+d | 0.167 (NS) | 0.334 (NS) | 0.373 (0.04) | 0.229 (NS) | −0.087 (NS) | −0.102 (NS) |
Vβ5+ CD4+d | 0.236 (NS) | 0.387 (0.04) | 0.371 (0.05) | 0.243 (NS) | −0.098 (NS) | 0.064 (NS) |
Vβ3+ CD8+d | 0.312 (NS) | 0.401 (0.03) | 0.279 (NS) | 0.195 (NS) | 0.014 (NS) | 0.275 (NS) |
Vβ5+ CD8+d | 0.152 (NS) | 0.305 (NS) | 0.336 (NS) | 0.124 (NS) | −0.109 (NS) | 0.089 (NS) |
LPA, lymphoproliferative assay; DTH, delayed-type hypersensitivity; ABt, antibody titer.
As stimulation index
As mm of induration at maximum diameter
As U/mL
As % of Vβ3 or Vβ5+ cells that expand after stimulation with the corresponding agonistic antibody